Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,116.00
Bid: 1,116.00
Ask: 1,118.00
Change: -36.00 (-3.13%)
Spread: 2.00 (0.179%)
Open: 1,140.00
High: 1,156.00
Low: 1,104.00
Prev. Close: 1,152.00
CVSG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

21 Jul 2014 07:00

RNS Number : 7799M
CVS Group plc
21 July 2014
 

 

21 July 2014

 

CVS Group plc ("CVS" or the "Group")

 

Trading Update

 

CVS, the UK's leading provider of integrated veterinary services, is pleased to provide the following trading update in respect of the financial year ended 30 June 2014. Comparative data relates to the year ended 30 June 2013 unless otherwise stated. The Group will announce its full year results on Friday 19 September 2014 and these are expected to be in line with market expectations.

 

Group revenue for the year showed total like-for-like growth of 6.9%. This figure benefitted from good weather throughout the winter months and is stated after adjusting for one extra day's trading in the year to 30 June 2013. Like-for-like sales performance was strong in all the main businesses, particularly in Animed Direct. CVS continues to see opportunities for organic growth across all of its activities and continues to invest in the estate to capitalise on this potential.

 

Strong organic growth has been achieved in the core veterinary practices especially in the second half of the year. Membership of our Healthy Pet Club loyalty schemes grew by 50,100 (44.8%), from 111,900 pets at the start of the year to 162,000 at the year end. In the previous year membership grew by 46,400. Based on the current run rate these schemes are now contributing over 11% of the total revenue from practices (2013: 9%).

 

The scale and increasing density of our practice network has enabled the Group to open four emergency out-of-hours centres during the year, bringing work previously performed by third parties into the Group. Further opportunities for similar changes will be sought during 2015.

 

Good progress has been made in developing our referrals business with organic growth continuing in the centres that we already operate. In July 2014 we purchased the freehold of Lumbry Park, Alton, Hampshire for £800,000 and we are now developing plans for fitting it out as a first-class multi-disciplinary referral centre. This centre is expected to open in the summer of 2015.

 

It is pleasing to report that significant growth has continued in Animed Direct, our online dispensary. It is currently generating some £10.4 million of annualised revenue, based on revenue for June 2014, compared with £6.7 million based on June 2013. The varying regulatory requirements in Europe have led to a slight delay in launching our planned local language European websites and the first is now expected to be launched within the next few months.

 

Acquisition activity has continued to play an important part in the Group's strategy. In addition to the seven practices acquired in the first half of the year, three practices - 3 Mile (Glasgow), Ashfield (3 sites around Halifax) and Castle (3 sites in Barnard Castle, County Durham) - and a pet crematorium (Silvermere Haven in Cobham) were acquired during the second half. These acquisitions extend the Practice Division's operations and the practices are an excellent geographic fit with the Group's existing surgeries. The acquisition of Silvermere Haven is an important step in the geographic development of our Crematoria Division and will allow almost all of our practices to be serviced internally.

 

All of the acquisitions have been successfully integrated into the Group. The aggregate turnover of acquisitions in their last financial year prior to acquisition totalled £13.3 million. The actual post acquisition turnover of businesses acquired during the year ended 30 June 2014 was £6.6m.

 

The Group now operates a total of 262 veterinary practices across the UK, an on-line dispensary, 5 diagnostic laboratories and 3 pet crematoria.

 

 

The Board is encouraged by the recent improvement in like-for-like sales performance, the continuing potential for further acquisitions and the general progress in all divisions of the Group.

 

 

For further enquiries please contact:

 

CVS Group plc: 01379 644 288

Simon Innes - Chief Executive

Nick Perrin - Finance Director

 

N+1 Singer (Nominated Adviser & Broker) 020 7496 3000

Aubrey Powell / Alex Wright

Nick Owen

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCKMGMNDRFGDZM
Date   Source Headline
16th Feb 201812:45 pmRNSPlacing Update
16th Feb 201811:05 amRNSClose of Accelerated Bookbuild
16th Feb 20187:01 amRNSProposed Accelerated Bookbuild
16th Feb 20187:00 amRNSInterim Results
15th Feb 20187:00 amRNSExercise of Options & TVR
1st Feb 20183:43 pmRNSHolding(s) in Company
31st Jan 20182:21 pmRNSTotal Voting Rights
24th Jan 20185:40 pmRNSHolding(s) in Company
22nd Jan 20184:10 pmRNSHolding(s) in Company
22nd Jan 20184:03 pmRNSHolding(s) in Company
19th Jan 201812:30 pmRNSLong Term Incentive Plan Awards
18th Jan 20187:00 amRNSTrading Statement
17th Jan 20185:15 pmRNSTrading Statement
15th Jan 20182:55 pmRNSExercise of Options & TVR
11th Jan 20189:48 amRNSHolding(s) in Company
9th Jan 20184:55 pmRNSHolding(s) in Company
5th Jan 20184:15 pmRNSHolding(s) in Company
4th Jan 20182:35 pmRNSHolding(s) in Company
2nd Jan 20188:35 amRNSTotal Voting Rights
2nd Jan 20187:00 amRNSDirectorate Change
29th Dec 201710:05 amRNSHolding(s) in Company
22nd Dec 20178:32 amRNSHolding(s) in Company
19th Dec 20177:00 amRNSBlock Admission
19th Dec 20177:00 amRNSExercise of Options, Directors' Dealing & TVR
18th Dec 20174:00 pmRNSHolding(s) in Company
13th Dec 20173:07 pmRNSExercise of Options & TVR
8th Dec 20174:39 pmRNSHolding(s) in Company
8th Dec 20177:00 amRNSDirector/PDMR Shareholding
7th Dec 20175:14 pmRNSHolding(s) in Company
30th Nov 20174:44 pmRNSTotal Voting Rights
30th Nov 20171:39 pmRNSResult of AGM
30th Nov 20177:00 amRNSAGM Statement
14th Nov 201712:12 pmRNSHolding(s) in Company
9th Nov 20174:15 pmRNSExercise of Options & TVR
2nd Nov 201710:33 amRNSPosting of Annual Report and Notice of AGM
31st Oct 20174:14 pmRNSTotal Voting Rights
24th Oct 20172:41 pmRNSBlock listing Interim Review
24th Oct 20171:39 pmRNSExercise of Options & TVR
9th Oct 20174:57 pmRNSHolding(s) in Company
6th Oct 20174:23 pmRNSHolding(s) in Company
29th Sep 20177:00 amRNSPreliminary Results
20th Sep 20175:24 pmRNSHolding(s) in Company
12th Sep 20173:41 pmRNSHolding(s) in Company
4th Sep 20172:53 pmRNSHolding(s) in Company
16th Aug 20173:46 pmRNSHolding(s) in Company
14th Aug 20173:10 pmRNSExercise of Options & TVR
31st Jul 201712:08 pmRNSExercise of Options & TVR
31st Jul 20177:00 amRNSTrading Update
26th Jul 20172:32 pmRNSHolding(s) in Company
25th Jul 20172:22 pmRNSExercise of Options & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.